Shares of California-based telehealth firm Hims & Hers Health (HIMS) gained 13.6% in early trade on Wednesday after the company reported better-than-expected financial results for the second quarter of 2021. Hims & Hers enables consumers to access medical treatment for dermatology, sexual health, mental health and primary care, among others, by connecting them to licensed healthcare professionals. The company reported a loss of $0.05 per share, narrower than the Street’s loss estimate of $0.10 per share but wider than the year-ago loss of $0.03 per share. Quarterly revenues surged 69% year-over-year to $60.7 million, surpassing analysts’ expectations of $56.49 million. The rise was driven by growth across all business segments.
https://www.tipranks.com/news/hims-q2-results-top-estimates-shares-gain-13-6-pre-market?utm_source=advfn.com&utm_medium=referral
Hims and Hers Health (NYSE:HIMS)
Gráfico Histórico do Ativo
De Nov 2021 até Dez 2021 Click aqui para mais gráficos Hims and Hers Health.
Hims and Hers Health (NYSE:HIMS)
Gráfico Histórico do Ativo
De Dez 2020 até Dez 2021 Click aqui para mais gráficos Hims and Hers Health.